High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.

Thirty-eight patients with previously treated Hodgkin's disease were given high dose combination chemotherapy using melphalan and BCNU and autologous bone marrow transplantation. In 25 patients etoposide was added in conventional dosage. During the course of the study the dose of melphalan was...

Descripción completa

Detalles Bibliográficos
Autores principales: Zulian, G. B., Selby, P., Milan, S., Nandi, A., Gore, M., Forgeson, G., Perren, T. J., McElwain, T. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247129/
https://www.ncbi.nlm.nih.gov/pubmed/2653400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247129/
https://www.ncbi.nlm.nih.gov/pubmed/2653400

Ejemplares similares